<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0188333.ref021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>van der Sanden</surname>
   <given-names>SM</given-names>
  </name>, 
  <name>
   <surname>Wu</surname>
   <given-names>W</given-names>
  </name>, 
  <name>
   <surname>Dybdahl-Sissoko</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Weldon</surname>
   <given-names>WC</given-names>
  </name>, 
  <name>
   <surname>Brooks</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>O'Donnell</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game</article-title>. 
  <source>Journal of virology</source>. 
  <year>2016</year>;
  <volume>90</volume>(
  <issue>4</issue>):
  <fpage>1694</fpage>â€“
  <lpage>704</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01464-15" xmlns:xlink="http://www.w3.org/1999/xlink">10.1128/JVI.01464-15</ext-link>
  </comment> ; PubMed Central PMCID: PMC4733985.
  <?supplied-pmid 26581994?>
  <pub-id pub-id-type="pmid">26581994</pub-id>
 </mixed-citation>
</ref>
